NFKB1 and B-cell non-Hodgkin lymphoma: In vivo findings, together with the in vitro induction of apoptosis in primary malignant B cells, highlighted for the first time the translational relevance of NF-kB inhibition in the treatment of B-cell lymphoma [52].